Filing Details

Accession Number:
0000059478-19-000258
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-23 15:54:38
Reporting Period:
2019-09-20
Accepted Time:
2019-09-23 15:54:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1596336 G Alfonso Zulueta Lilly Corporate Center
Indianapolis IN 46285
Svp & President, Lilly Int'l No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-09-20 4,500 $117.00 33,806 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,564 Indirect 401(k)
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2019.